Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Einschlusskriterien
Description

Einschlusskriterien

Alias
UMLS CUI-1
C1512693
Alter
Description

Age

Data type

boolean

Alias
UMLS CUI-1
C0001779
Weibliches Geschlecht
Description

Female

Data type

boolean

Alias
UMLS CUI-1
C0086287
metastasierendes Endometriumkarzinom
Description

Metastatic endometrial carcinoma

Data type

boolean

Alias
UMLS CUI-1
C0813148
Postmenopausal
Description

Postmenopausal

Data type

boolean

Alias
UMLS CUI-1
C0232970
Hormonrezeptor positiv
Description

Hormonreceptor positive tumor

Data type

boolean

Alias
UMLS CUI-1
C1563119
Ausschlusskriterien
Description

Ausschlusskriterien

Alias
UMLS CUI-1
C0680251
Vorbehandlung mit Fulvestrant
Description

Pre-treatment with Fulvestrant

Data type

boolean

Alias
UMLS CUI-1
C1550147
Vorherige endokrine Therapie
Description

Previous endocrine therapy

Data type

boolean

Alias
UMLS CUI-1
C0262926
UMLS CUI-2
C0279025
Vorheriges Malignom
Description

Previous malignancy

Data type

boolean

Alias
UMLS CUI-1
C0262926
UMLS CUI-2
C0006826

Similar models

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Einschlusskriterien
C1512693 (UMLS CUI-1)
Age
Item
Alter
boolean
C0001779 (UMLS CUI-1)
Female
Item
Weibliches Geschlecht
boolean
C0086287 (UMLS CUI-1)
Metastatic endometrial carcinoma
Item
metastasierendes Endometriumkarzinom
boolean
C0813148 (UMLS CUI-1)
Postmenopausal
Item
Postmenopausal
boolean
C0232970 (UMLS CUI-1)
Hormonreceptor positive tumor
Item
Hormonrezeptor positiv
boolean
C1563119 (UMLS CUI-1)
Item Group
Ausschlusskriterien
C0680251 (UMLS CUI-1)
Pre-treatment with Fulvestrant
Item
Vorbehandlung mit Fulvestrant
boolean
C1550147 (UMLS CUI-1)
Previous endocrine therapy
Item
Vorherige endokrine Therapie
boolean
C0262926 (UMLS CUI-1)
C0279025 (UMLS CUI-2)
Previous malignancy
Item
Vorheriges Malignom
boolean
C0262926 (UMLS CUI-1)
C0006826 (UMLS CUI-2)